Salter-Cid Luisa 4
4 · Jounce Therapeutics, Inc. · Filed Feb 12, 2021
Insider Transaction Report
Form 4
Salter-Cid Luisa
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-02-10+31,400→ 31,400 totalExercise: $12.36Exp: 2031-02-10→ Common Stock (31,400 underlying)
Footnotes (1)
- [F1]The option was granted on February 10, 2021 and will vest in equal quarterly installments during the twelve quarters following the grant date, subject the to Reporting Person's continued service as a director.